×
These labels refer to actions, prepositions, spatial relations, comparatives or preposition phrases. The dataset has 37993 instances of visual relationships and ...
People also ask
We aimed to study whether the addition of bortezomib to lenalidomide and dexamethasone would improve progression-free survival and provide ...
Dec 12, 2023 · LBA 1: Phase 3 Randomized Study of Daratumumab (DARA) + Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Vrd Alone in Patients (Pts) ...
Label with FCC ID · FCC ID: VRD-GW2 · ID Label/Location Info.
Use saved searches to filter your results more quickly ... This repository has been archived by the owner on Jun 15, 2023. It is now read-only.
Sep 8, 2015 · Goals of therapy: RVd or VRd is given to alleviate myeloma symptoms and slow the progression of multiple myeloma, not to cure this disease.
Nov 15, 2022 · Abstract. Introduction: The use of bortezomib, lenalidomide and dexamethasone (VRd) as induction triplet has resulted in deep and durable ...
Aug 1, 2022 · VRd is a combination of drugs used to treat multiple myeloma ... VRd Regimen for Multiple Myeloma ... label, phase 3, randomized, controlled trial.
Here, the VRd regimen comprised: bortezomib given as 1.3mg/m2 IV on days 1,4,8,11, lenalidomide 25mg po on days 1-14 and dexamethasone 20mg on days of and days ...